AEGiS-BKREV: Mosby's GenRx: The Complete Reference for Generic and Brand Drugs, 9th edition. 1999. Books In Print
click here to return to Books In Print main menu

Mosby's GenRx: The Complete Reference for Generic and Brand Drugs, 9th edition. 1999.

Mosby, Inc., 11830 Westline Industrial Drive, St. Louis, MO 63146. 1v., various paging. ISBN 0-323-00625-6. $71.95.


Mosby's GenRx has become the most complete listing of prescription pharmaceuticals available today. It is an easy to use compilation that provides everything that one would want to know about a prescribed pharmaceutical. For each entry the following is given: categories; USPDI, vol. II off-label uses; FDA drug class; brand names; cost of therapy; prescribing information; how supplied; and supplier profiles. The prescribing information provides the following: description, clinical pharmacology, clinical studies, indications and usage, contraindications, adverse reactions, warnings, precautions, drug interactions, drug abuse and dependence, overdosage, dosage and administration, animal pharmacology, references, Centers for Disease Control dosage information, and patient information.

Other important information that is provided includes FDA pregnancy categories; DEA schedules of controlled substances; Poison Control Centers in the United States and Canada; Directory of AIDS Drug Assistance Programs; Key addresses and phone numbers; Oral solid dosage forms that should not be crushed; discontinued products; manufacturers listed by NDC number; drug names that look alike and sound alike; drug ID imprint guide; and comparative tables.

This is a highly recommended reference source that should be available in all public, academic and medical libraries. Pharmacies should consider this as a major source of information as should all hospitals.


Keywords: Drugs; Therapy)

Copyright (c) 1999 - Board of Trustees of the University of Illinois. Reviews may be reprinted or redistributed for the noncommercial purpose of scientific or educational advancement granted by Sections 107 and 108 of the Copyright Revision Act of 1976. For other reprinting, redistribution, or translation, address requests to H. Robert Malinowsky, University of Illinois at Chicago Library, PO Box 8198, Chicago, IL 60680 or electronically to hrm@uic.edu.KWDdrugs;therapy)
990901
BK990946


Copyright © 1999 - The University of Illinois at Chicago. All materials in the journal are subject to copyright by the Board of Trustees of the University of Illinois and may be reprinted or redistributed for the noncommercial purpose of scientific or educational advancement granted by Sections 107 and 108 of the Copyright Revision Act of 1976. For other reprinting, redistribution, or translation, address requests to H. Robert Malinowsky, University of Illinois at Chicago Library, PO Box 8198, Chicago, IL 60680 or electronically to hrm@uic.edu.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .